1. Home
  2. TNXP vs GPRO Comparison

TNXP vs GPRO Comparison

Compare TNXP & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • GPRO
  • Stock Information
  • Founded
  • TNXP 2007
  • GPRO 2004
  • Country
  • TNXP United States
  • GPRO United States
  • Employees
  • TNXP N/A
  • GPRO N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • GPRO Industrial Machinery/Components
  • Sector
  • TNXP Health Care
  • GPRO Consumer Discretionary
  • Exchange
  • TNXP Nasdaq
  • GPRO Nasdaq
  • Market Cap
  • TNXP 213.7M
  • GPRO 194.6M
  • IPO Year
  • TNXP N/A
  • GPRO 2014
  • Fundamental
  • Price
  • TNXP $18.12
  • GPRO $1.77
  • Analyst Decision
  • TNXP Buy
  • GPRO
  • Analyst Count
  • TNXP 1
  • GPRO 0
  • Target Price
  • TNXP $70.00
  • GPRO N/A
  • AVG Volume (30 Days)
  • TNXP 734.4K
  • GPRO 8.7M
  • Earning Date
  • TNXP 11-07-2025
  • GPRO 11-06-2025
  • Dividend Yield
  • TNXP N/A
  • GPRO N/A
  • EPS Growth
  • TNXP N/A
  • GPRO N/A
  • EPS
  • TNXP N/A
  • GPRO N/A
  • Revenue
  • TNXP $9,831,000.00
  • GPRO $746,731,000.00
  • Revenue This Year
  • TNXP $14.79
  • GPRO N/A
  • Revenue Next Year
  • TNXP $933.49
  • GPRO $9.72
  • P/E Ratio
  • TNXP N/A
  • GPRO N/A
  • Revenue Growth
  • TNXP N/A
  • GPRO N/A
  • 52 Week Low
  • TNXP $6.76
  • GPRO $0.40
  • 52 Week High
  • TNXP $130.00
  • GPRO $3.05
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 34.78
  • GPRO 40.52
  • Support Level
  • TNXP $18.53
  • GPRO $1.67
  • Resistance Level
  • TNXP $18.96
  • GPRO $2.73
  • Average True Range (ATR)
  • TNXP 1.05
  • GPRO 0.17
  • MACD
  • TNXP 0.39
  • GPRO -0.06
  • Stochastic Oscillator
  • TNXP 24.31
  • GPRO 9.43

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

Share on Social Networks: